| Cat. No. |
Product |
Quantity/Size |
Price |
Data |
|
| FHD18110B |
Anti-Human TSHR / LGR3 (M22) mAb |
100 ug |
$475.00
|
 |
BUY
|
| FHD18110C |
Anti-Human TSHR / LGR3 (M22) mAb |
1.0 mg |
$1,720.00
|
|
BUY
|
| FHD18110A |
Anti-Human TSHR / LGR3 (M22) mAb |
50 ug |
$330.00
|
|
BUY
|
| CSI12348 |
Armenian Hamster Anti-Mouse TNF-alpha (Clone TN3-19.12) mAb |
1.0 mg |
$595.00
|
|
BUY
|
| CSB119B |
Human anti-Basigin / CD147 (Meplazumab) mAb |
1.0 mg |
$1,395.00
|
|
BUY
|
| CSB119A |
Human anti-Basigin / CD147 (Meplazumab) mAb |
100 µg |
$475.00
|
|
BUY
|
| CSB111A |
Human anti-ERBB2 / HER2 (Trastuzumab emtansine) mAb |
100 µg |
$455.00
|
|
BUY
|
| CSB111B |
Human anti-ERBB2 / HER2 (Trastuzumab emtansine) mAb |
1.0 mg |
$1,335.00
|
|
BUY
|
| CSB112A |
Human anti-IL-17A (Ixekizumab) mAb |
100 µg |
$470.00
|
|
BUY
|
| CSB112B |
Human anti-IL-17A (Ixekizumab) mAb |
1.0 mg |
$1,375.00
|
|
BUY
|
| CSB115B |
Human anti-IL-4 Receptor Subunit alpha (Dupilumab) mAb |
1.0 mg |
$1,375.00
|
|
BUY
|
| CSB115A |
Human anti-IL-4 Receptor Subunit alpha (Dupilumab) mAb |
100 µg |
$470.00
|
|
BUY
|
| CSB113A |
Human anti-IL-6 Receptor (Sarilumab) mAb |
100 µg |
$470.00
|
|
BUY
|
| CSB113B |
Human anti-IL-6 Receptor (Sarilumab) mAb |
1.0 mg |
$1,375.00
|
|
BUY
|
| CSB120B |
Human anti-IL-6 Receptor (Tocilizumab) mAb |
1.0 mg |
$1,375.00
|
|
BUY
|
| CSB120A |
Human anti-IL-6 Receptor (Tocilizumab) mAb |
100 µg |
$470.00
|
|
BUY
|
| CSB118A |
Human anti-PD-1 (Cemiplimab) mAb |
100 µg |
$475.00
|
|
BUY
|
| CSB118B |
Human anti-PD-1 (Cemiplimab) mAb |
1.0 mg |
$1,395.00
|
|
BUY
|
| CSB114B |
Human anti-PD-1 Receptor (Nivolumab) mAb |
1.0 mg |
$1,375.00
|
|
BUY
|
| CSB114A |
Human anti-PD-1 Receptor (Nivolumab) mAb |
100 µg |
$470.00
|
|
BUY
|
| CSB116A |
Human anti-PD-1 Receptor (Pembrolizumab) mAb |
100 µg |
$470.00
|
|
BUY
|
| CSB116B |
Human anti-PD-1 Receptor (Pembrolizumab) mAb |
1.0 mg |
$1,375.00
|
|
BUY
|
| CSB117A |
Human anti-PD-L1 (Avelumab) mAb |
100 µg |
$470.00
|
|
BUY
|
| CSB117B |
Human anti-PD-L1 (Avelumab) mAb |
1.0 mg |
$1,375.00
|
|
BUY
|
| CPC534B |
Human Anti-SARS-CoV-2 Spike-RBD Bamlanivimab (LY-CoV555）Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC534A |
Human Anti-SARS-CoV-2 Spike-RBD Bamlanivimab (LY-CoV555）Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC538A |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike Glycoprotein Sotrovimab (VIR-7831 / GSK4182136) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC538B |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike Glycoprotein Sotrovimab (VIR-7831 / GSK4182136) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC535A |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike-RBD Cilgavimab (AZD1061) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC535B |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike-RBD Cilgavimab (AZD1061) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC537A |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike-RBD Tixagevimab (AZD8895) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC537B |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike-RBD Tixagevimab (AZD8895) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC523B |
Human Anti-SARS-CoV-2 Spike RBD (B38) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC522B |
Human Anti-SARS-CoV-2 Spike RBD (B38) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC523A |
Human Anti-SARS-CoV-2 Spike RBD (B38) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC522A |
Human Anti-SARS-CoV-2 Spike RBD (B38) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC521A |
Human Anti-SARS-CoV-2 Spike RBD (H4) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC521B |
Human Anti-SARS-CoV-2 Spike RBD (H4) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC520A |
Human Anti-SARS-CoV-2 Spike S1 (CR3022) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC520B |
Human Anti-SARS-CoV-2 Spike S1 (CR3022) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC542C |
Human Anti-SARS-CoV-2 Spike-RBD (002-S21F2) Broad-Neutralizing mAb |
1.0 mg |
Please Inquire |
|
BUY
|
| CPC513B |
Human Anti-SARS-CoV-2 Spike-RBD (EY6A) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC513A |
Human Anti-SARS-CoV-2 Spike-RBD (EY6A) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC539B |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC539C |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
1.0 mg |
Please Inquire |
|
BUY
|
| CPC539A |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC511B |
Human Anti-SARS-CoV-2 Spike-RBD Casirivimab(REGN10933) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC511A |
Human Anti-SARS-CoV-2 Spike-RBD Casirivimab(REGN10933) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC516B |
Human Anti-SARS-CoV-2 Spike-RBD Etesevimab (CB6, JS016, LY-CoV-016) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC516A |
Human Anti-SARS-CoV-2 Spike-RBD Etesevimab (CB6, JS016, LY-CoV-016) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC512B |
Human Anti-SARS-CoV-2 Spike-RBD Imdevimab (REGN10987) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC541A |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC541B |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC541C |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
1.0 mg |
Please Inquire |
|
BUY
|
| CMA006A |
Human anti-TNF alpha (Clone D2E7) Adalimumab |
200 μg |
$690.00
|
|
BUY
|
| CMA006B |
Human anti-TNF alpha (Clone D2E7) Adalimumab |
1.0 mg |
$2,900.00
|
|
BUY
|
| CSB104B |
Human anti-TNF alpha (Clone D2E7, Adalimumab) mAb |
1.0 mg |
$1,480.00
|
|
BUY
|
| CSB104A |
Human anti-TNF alpha (Clone D2E7, Adalimumab) mAb |
100 µg |
$500.00
|
|
BUY
|
| FHD18010A |
Humanized Anti-Human PRLR (Clone h16f) mAb |
50 ug |
$330.00
|
|
BUY
|
| FHD18010B |
Humanized Anti-Human PRLR (Clone h16f) mAb |
100 ug |
$475.00
|
|
BUY
|
| FHD18010C |
Humanized Anti-Human PRLR (Clone h16f) mAb |
1.0 mg |
$1,715.00
|
|
BUY
|
| FHB65410B |
Humanized Anti-Human SLC34A2 / NaPi2b (SAA0766) mAb |
1.0 mg |
$1,562.00
|
|
BUY
|
| FHB65410A |
Humanized Anti-Human SLC34A2 / NaPi2b (SAA0766) mAb |
100 ug |
$330.00
|
|
BUY
|
| CSB107B |
Humanized anti-TNF alpha (Certolizumab Pegol) mAb (see DHB94401) |
1.0 mg |
Please Inquire |
|
BUY
|
| CSB107A |
Humanized anti-TNF alpha (Certolizumab Pegol) mAb (see DHB94401) |
100 µg |
Please Inquire |
|
BUY
|
| VVV22001B |
InVivoMAb Anti-EBV/HHV4 gB/BALF4 (Iv0133) |
1 mg |
$1,715.00
|
|
BUY
|
| VVV22001A |
InVivoMAb Anti-EBV/HHV4 gB/BALF4 (Iv0133) |
100 µg |
$475.00
|
|
BUY
|
| VVV22002B |
InVivoMAb Anti-EBV/HHV4 gB/BALF4 (Iv0134) |
1 mg |
$1,715.00
|
|
BUY
|
| VVV22002A |
InVivoMAb Anti-EBV/HHV4 gB/BALF4 (Iv0134) |
100 µg |
$475.00
|
|
BUY
|
| VVV02903A |
InVivoMAb Anti-HCMV/HHV5 gB Neutralizing Antibody(1G2) |
100 µg |
$475.00
|
|
BUY
|
| VVV02903B |
InVivoMAb Anti-HCMV/HHV5 gB Neutralizing Antibody(1G2) |
1.0 mg |
$1,715.00
|
|
BUY
|
| VVV02901A |
InVivoMAb Anti-HCMV/HHV5 gB Neutralizing Antibody(SM5-1) |
100 µg |
$475.00
|
|
BUY
|
| VVV02901B |
InVivoMAb Anti-HCMV/HHV5 gB Neutralizing Antibody(SM5-1) |
1.0 mg |
$1,670.00
|
|
BUY
|
| VHB98601A |
InVivoMAb Anti-Human APOE (Iv0128) |
100 µg |
$475.00
|
|
BUY
|
| VHB98601B |
InVivoMAb Anti-Human APOE (Iv0128) |
1 mg |
$1,715.00
|
|
BUY
|
| VHA94801A |
InVivoMAb Anti-Human APOE (Iv0131) |
100 µg |
$475.00
|
|
BUY
|
| VHA94801B |
InVivoMAb Anti-Human APOE (Iv0131) |
1 mg |
$1,715.00
|
|
BUY
|
| VHC01801B |
InVivoMAb Anti-Human CXCL4/PF4 (Iv0086) |
1 mg |
$1,715.00
|
|
BUY
|
| VHC01801A |
InVivoMAb Anti-Human CXCL4/PF4 (Iv0086) |
100 µg |
$475.00
|
|
BUY
|
| VHB48101A |
InVivoMAb Anti-Human DKK1 (DKN-01) |
100 µg |
$475.00
|
|
BUY
|
| VHB48101B |
InVivoMAb Anti-Human DKK1 (DKN-01) |
1 mg |
$1,670.00
|
|
BUY
|
| VHB63001B |
InVivoMAb Anti-Human GDF11/BMP11 (Iv0062) |
1 mg |
$1,715.00
|
|
BUY
|
| VHB63001A |
InVivoMAb Anti-Human GDF11/BMP11 (Iv0062) |
100 µg |
$475.00
|
|
BUY
|
| VHB94601B |
InVivoMAb Anti-Human IFN α2/IFNA2 (Iv0001) |
1 mg |
$1,715.00
|
|
BUY
|
| VHB94601A |
InVivoMAb Anti-Human IFN α2/IFNA2 (Iv0001) |
100 µg |
$475.00
|
|
BUY
|
| VHD42201B |
InVivoMAb Anti-Human IL11 (X203) |
1.0 mg |
$1,715.00
|
|
BUY
|
| VHD42201A |
InVivoMAb Anti-Human IL11 (X203) |
100 µg |
$475.00
|
|
BUY
|
| VHG84901B |
InVivoMab Anti-Human IL11RA (X209) |
1.0 mg |
$1,715.00
|
|
BUY
|
| VHG84901A |
InVivoMab Anti-Human IL11RA (X209) |
100 µg |
$475.00
|
|
BUY
|
| VHH28801B |
InVivoMAb Anti-Human IL17A (Iv0029) |
1 mg |
$1,715.00
|
|
BUY
|
| VHH28801A |
InVivoMAb Anti-Human IL17A (Iv0029) |
100 µg |
$475.00
|
|
BUY
|
| VHE32302A |
InVivoMAb Anti-Human TNFSF9 / 4-1BBL Antibody (Iv0140) |
100 µg |
$475.00
|
|
BUY
|
| VHE32302B |
InVivoMAb Anti-Human TNFSF9 / 4-1BBL Antibody (Iv0140) |
1 mg |
$1,715.00
|
|
BUY
|
| VHD18102A |
InVivoMAb Anti-Human TSHR/LGR3 (5C9) |
100 µg |
$475.00
|
|
BUY
|
| VHD18102B |
InVivoMAb Anti-Human TSHR/LGR3 (5C9) |
1 mg |
$1,715.00
|
|
BUY
|
| VHK26801A |
InVivoMAb Anti-Human VSIG4/CRIg Antibody (Iv0141) |
100 µg |
$475.00
|
|
BUY
|
| VHK26801B |
InVivoMAb Anti-Human VSIG4/CRIg Antibody (Iv0141) |
1 mg |
$1,715.00
|
|
BUY
|
| VVV07505A |
InVivoMAb Anti-MERS-CoV RBD (m336) |
100 µg |
$475.00
|
|
BUY
|
| VVV07505B |
InVivoMAb Anti-MERS-CoV RBD (m336) |
1 mg |
$1,670.00
|
|
BUY
|
| VMD10801A |
InVivoMAb Anti-Mouse CD19 & CD3e Bispecific Antibody (Iv0224) |
100 µg |
$630.00
|
|
BUY
|
